| Citation: |
ZENG Zhiben, WU Xinfeng. Effect of triple therapy combined with betahistine in treating residual dizziness of patients with benign paroxysmal positional vertigo after repositioning[J]. Journal of Clinical Medicine in Practice, 2024, 28(13): 92-97. DOI: 10.7619/jcmp.20233966
|
To evaluate the effects of triple therapy combined with betahistine on cerebral blood circulation and cutaneous sympathetic response (SSR) in patients with residual dizziness after reposition of benign paroxysmal positional vertigo.
A total of 196 patients with residual dizziness after reposition of benign paroxysmal positional vertigo were randomly divided into two groups, with 98 cases in each group. Control group was treated with betahistine, while experimental group was treated with betahistine and triple therapy (compound manipulation, transcranial magnetic stimulation and specific body position), and both groups were treated for 2 courses of treatment, with 7 days as a course of treatment. Efficacy, duration of residual dizziness, the scores of the Dizziness Handicap Inventory (DHI), the Visual Analogue Scale (VAS), the Activity Balance Confidence (ABC), the Hamilton Anxiety Scale (HAMA) and the Vestibular Symptom Index (VSI) before treatment and after the course of the treatment, SSR, and values of mean blood flow velocity (Vm) of cerebral vertebral artery (VA) and basilar artery (BA) were compared between the two groups.
The duration of residual dizziness in the experimental group was (10.25±3.74) days, which was significantly shorter than (15.26±2.98) days in the control group (P < 0.001); the total treatment effective rate of the experimental group was 93.88%, which was significantly higher than 79.59% of the control group (P < 0.05). At the end of the course, the scores of the three dimensions of the DHI in the experimental group were significantly lower than those in the control group (P < 0.05). At the end of the course, the VAS, the HAMA and the VSI scores in the experimental group were significantly lower than those in the control group, while the ABC score was significantly higher than that in the control group (P < 0.05). At the end of the course, the SSR amplitude value in the experimental group was significantly lower than that in the control group, while the SSR latency value was significantly higher than that in the control group (P < 0.05). At the end of the course, the values of Vm of VA and BA in the experimental group were significantly higher than those in the control group (P < 0.05).
The combination of triple therapy and betahistine has a definite therapeutic effect on residual dizziness after reposition of benign paroxysmal positional vertigo, which can alleviate dizziness and vestibular symptoms, enhance activity balance confidence, relieve anxiety degree, and improve SSR and cerebral blood circulation.
| [1] |
LIU W, PAN C L, WANG X C, et al. Clinical effect of vestibular rehabilitation on benign paroxysmal positional vertigo: a protocol for systematic review[J]. Medicine, 2021, 100(3): e23906. doi: 10.1097/MD.0000000000023906
|
| [2] |
CHEN J B, ZHANG S L, CUI K, et al. Risk factors for benign paroxysmal positional vertigo recurrence: a systematic review and meta-analysis[J]. J Neurol, 2021, 268(11): 4117-4127. doi: 10.1007/s00415-020-10175-0
|
| [3] |
ICHIJO H. Five subtypes of benign paroxysmal positional vertigo[J]. J Laryngol Otol, 2021, 135(10): 874-878. doi: 10.1017/S0022215121002097
|
| [4] |
ÇETIN Y S, ÇAĜAÇ A, DÜZENLI U, et al. Residual dizziness in elderly patients after benign paroxysmal positional Vertigo[J]. ORL J Otorhinolaryngol Relat Spec, 2022, 84(2): 122-129. doi: 10.1159/000516961
|
| [5] |
王富军, 张甜甜. 氟桂利嗪联合倍他司汀治疗颈性眩晕的临床疗效[J]. 实用临床医药杂志, 2020, 24(11): 68-70, 74. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202011019.htm
|
| [6] |
中华耳鼻咽喉头颈外科杂志编辑委员会, 中华医学会耳鼻咽喉头颈外科学分会. 良性阵发性位置性眩晕诊断和治疗指南(2017)[J]. 中华耳鼻咽喉头颈外科杂志, 2017, 52(3): 173-177. https://cpfd.cnki.com.cn/Article/CPFDTOTAL-ZGZP201709006014.htm
|
| [7] |
国家药品监督管理局. 中药新药临床研究指导原则[M]. 北京: 中国医药科技出版社, 2002: 349-349.
|
| [8] |
CHOI S Y, CHO J W, CHOI J H, et al. Effect of the epley maneuver and brandt-daroff exercise on benign paroxysmal positional Vertigo involving the posterior semicircular canal cupulolithiasis: a randomized clinical trial[J]. Front Neurol, 2020, 11: 603541. doi: 10.3389/fneur.2020.603541
|
| [9] |
WIENER-VACHER S R, QUAREZ J, PRIOL A L. Epidemiology of vestibular impairments in a pediatric population[J]. Semin Hear, 2018, 39(3): 229-242. doi: 10.1055/s-0038-1666815
|
| [10] |
HUI J, LEI Q, JI Z, et al. Betahistine alleviates benign paroxysmal positional vertigo (BPPV) through inducing production of multiple CTRP family members and activating the ERK1/2-AKT/PPARy pathway[J]. Biol Res, 2022, 55(1): 16. doi: 10.1186/s40659-022-00385-3
|
| [11] |
SAYIN I, KOÇ R H, TEMIRBEKOV D, et al. Betahistine add-on therapy for treatment of subjects with posterior benign paroxysmal positional vertigo: a randomized controlled trial[J]. Braz J Otorhinolaryngol, 2022, 88(3): 421-426. doi: 10.1016/j.bjorl.2020.07.011
|
| [12] |
WU P X, CAO W Z, HU Y, et al. Effects of vestibular rehabilitation, with or without betahistine, on managing residual dizziness after successful repositioning manoeuvres in patients with benign paroxysmal positional vertigo: a protocol for a randomised controlled trial[J]. BMJ Open, 2019, 9(6): e026711. doi: 10.1136/bmjopen-2018-026711
|
| [13] |
谢涛, 黄流清. 倍他司汀联合利多卡因治疗良性阵发性位置性眩晕患者管石复位后残余头晕的疗效[J]. 中国新药与临床杂志, 2019, 38(3): 165-169. https://www.cnki.com.cn/Article/CJFDTOTAL-XYYL201903010.htm
|
| [14] |
ACAR B, KARASEN R M, BURAN Y. Efficacy of medical therapy in the prevention of residual dizziness after successful repositioning maneuvers for Benign Paroxysmal Positional Vertigo (BPPV)[J]. B-ENT, 2015, 11(2): 117-121.
|
| [15] |
李虹, 蔡以力, 杨胜亚. 从"补肾调督" 探讨针刺治疗中老年耳石症复位后残余头晕的取穴思路[J]. 北京中医药, 2019, 38(1): 45-47. https://www.cnki.com.cn/Article/CJFDTOTAL-BJZO201901014.htm
|
| [16] |
赵子烨. 针刺治疗耳石症复位后残余头晕的临床观察[D]. 太原: 山西中医药大学, 2021.
|
| [17] |
周海旺. 开天门复合手法治疗颈性眩晕的临床研究[D]. 广州: 广州中医药大学, 2012.
|
| [18] |
杜青, 吴常征, 顾宝东. 晕痛针治疗耳石症经手法复位后残留症状的临床效果[J]. 广西医学, 2018, 40(4): 449-450, 453. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYX201804026.htm
|
| [19] |
尹贻锟, 王佳林, 孙君志. 不同频率重复经颅磁刺激对脑卒中后认知障碍疗效的Meta分析[J]. 中国组织工程研究, 2023, 27(20): 3274-3280. https://www.cnki.com.cn/Article/CJFDTOTAL-XDKF202320024.htm
|
| [20] |
王冰, 李玮, 李六一, 等. 低频经颅磁刺激治疗阵发性位置性眩晕患者成功手法复位后残余头晕的疗效观察[J]. 中华物理医学与康复杂志, 2017, 39(4): 286-289.
|
| [21] |
HAGEMAN K N, CHOW M R, ROBERTS D, et al. Binocular 3D otolith-ocular reflexes: responses of normal chinchillas to tilt and translation[J]. J Neurophysiol, 2020, 123(1): 243-258.
|
| [22] |
钱淑霞, 张晓玲, 官俏兵. 良性阵发性位置性眩晕患者残余头晕的皮肤交感反应研究[J]. 中国耳鼻咽喉头颈外科, 2016, 23(9): 546-548. https://www.cnki.com.cn/Article/CJFDTOTAL-EBYT201609016.htm
|
| 1. |
毕勇志，马芬，宋琳琳. 血清HBP、CRP、PCT在早期毛细血管渗漏综合征患者中的表达分析. 罕少疾病杂志. 2024(02): 111-112+120 .
| |
| 2. |
陈雯，钱风华，孙旗，丁纯蕾，杨家豪，姜旭升，沈梦雯. 四逆升降散干预“肝-脾轴”改善脓毒症急性肺损伤预后的临床研究. 中国中医急症. 2024(11): 1929-1933 .
| |
| 3. |
林柏柏，赵雷，丁纯蕾，钱义明，张琼，谭美春，陆云霞，沈梦雯. 四逆升降散对脓毒症毛细血管渗漏综合征患者凝血功能的影响. 中国中医急症. 2024(11): 1934-1937 .
| |
| 4. |
闫雨蒙，徐霄龙，李博，郭玉红，刘清泉. 2000—2022年中医药治疗脓毒症研究文献的知识图谱可视化分析. 中医杂志. 2023(16): 1700-1706 .
| |
| 5. |
谷翠红，王阳，林丽，王丽红，张志华. 抗胸腺细胞球蛋白联合环孢素A治疗儿童重型再生障碍性贫血诱发毛细血管渗透综合征1例. 临床荟萃. 2023(09): 819-822 .
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: